PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products in Indonesia. The company operates through three segments: Pharmaceutical, Consumer Products, and Others. It also trades in medical and laboratory equipment and supplies; operates health care clinics; and offers dental and other equipment, as well as calibration services. In addition, the company engages in the trading of raw materials for pharmaceutical products; consumable products for hemodialysis therapy; and food and beverages. Further, it offers warehousing services, including chiller, cool, and ambient rooms, as well as container chiller. The company was formerly known as PT Arya Gupta Cempaka and changed its name to PT Enseval Putera Megatrading Tbk. in August 1993. The company was incorporated in 1973 and is headquartered in East Jakarta, Indonesia. PT Enseval Putera Megatrading Tbk. is a subsidiary of PT Kalbe Farma Tbk.
| Nama Perusahaan | Enseval Putera Megatrading Tbk. |
| Sektor | Barang Konsumen Primer |
| Sub Sektor | Perdagangan Ritel Barang Primer |
| Industri | Perdagangan Ritel Barang Primer |
| Sub Industri | Ritel & Distributor Obat-obatan |
| Jumlah saham beredar | 2,708,640,000 lembar |
| Market Cap | 6,311,131,200,000 | |
| Sales | 427,618,091,693,865,024 | (IDR) |
| Net Income | 10,327,478,438,865,000 | (IDR) |
| Equity | 7,112,647,230,630 | (IDR) |
| Free Cash | 0 | (IDR) |
| Item | Highlight | Score |
|---|---|---|
| Market Cap vs Equitas | Nilai Equitas di atas market Cap | 1 |
| PER | Valuasi PER < 10 | 1 |
| Net Profit | Rasio profitabilitas kurang dari 10% | 0 |
| Return On Equity | Return On Equity kurang bagus, < 15% | 0 |
| Rasio Hutang | Rasio hutang : Equity kurang dari 1 | 1 |
| Current Ratio | Liabilities lebih besar daripada aset lancar | 0 |
| Harga Wajar | Harga saham masih undervalued (3,875) | 1 |
| tahun | TTM | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 28,507,872,779,591 | 28,027,488,218,598 | 25,673,756,765,637 | 22,545,419,368,639 | 22,226,912,485,948 | 20,604,487,293,751 |
| Gross Profit | 2,921,033,927,384 | 2,976,639,328,157 | 2,764,336,688,571 | 2,418,744,942,466 | 2,412,947,549,993 | 2,361,491,053,417 |
| Operating Income | 991,356,205,785 | 1,095,534,128,195 | 1,034,225,947,573 | 767,385,522,011 | 747,360,775,252 | 834,841,222,040 |
| Pretax Income | 888,574,901,713 | 1,096,529,518,781 | 1,091,263,311,440 | 882,739,797,483 | 813,103,428,517 | 879,481,177,101 |
| Net Income | 688,498,562,591 | 847,532,822,398 | 847,881,142,916 | 680,597,939,678 | 580,629,918,596 | 653,064,164,661 |
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Aset | 10,402,356,853,033 | 9,729,919,645,520 | 9,211,731,059,218 | 8,704,958,834,283 | 8,322,960,974,230 |
| Aset Lancar | 8,783,144,098,407 | 8,128,487,195,074 | 7,540,695,065,075 | 7,120,602,478,197 | 6,960,395,955,329 |
| Other Current Asset | 0 | 204,896,093,953 | 160,488,933,403 | 143,683,022,642 | 162,747,201,354 |
| Total Liabilities | 3,264,730,959,090 | 2,882,998,501,598 | 2,652,274,698,711 | 2,575,650,387,235 | 2,535,106,096,057 |
| Total Equities | 7,112,647,230,630 | 6,831,085,432,589 | 6,542,589,036,710 | 6,128,081,727,958 | 5,786,788,882,068 |
| TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Kas dari Aktivitas Operasi | -288,192,280,189 | -29,999,829,900 | 404,805,061,273 | 980,695,031,727 | 248,919,605,641 | 543,778,934,884 |
| Kas dari Aktivitas Investasi | 144,297,152,999 | 139,908,551,448 | -133,804,515,916 | -156,533,492,180 | -262,862,775,722 | -76,285,903,711 |
| Kas dari Aktivitas Pembiayaan | -589,541,046,604 | -450,816,183,331 | -566,184,742,828 | -246,891,613,231 | -249,963,628,189 | -18,959,226,594 |
| Arus Kas Bebas | 0 | 0 | 0 | 0 | 0 | 0 |